Gene · 2549
Papers2,374
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 2,374
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Monocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis. | Am J Physiol Cell Physiol | 2023 | 37694283 | PubTator, text mining | PubMed |
| SHH medulloblastoma and very early onset of bowel polyps in a child with PTEN hamartoma tumor syndrome. | Front Mol Neurosci | 2023 | 37692099 | PubTator, text mining | PubMed |
| IGF1R Contributes to Cell Proliferation in ALK-Mutated Neuroblastoma with Preference for Activating the PI3K-AKT Signaling Pathway. | Cancers (Basel) | 2023 | 37686528 | PubTator, text mining | PubMed |
| Structures of liganded glycosylphosphatidylinositol transamidase illuminate GPI-AP biogenesis. | Nat Commun | 2023 | 37684232 | PubTator, text mining | PubMed |
| SHP2: A Pleiotropic Target at the Interface of Cancer and Its Microenvironment. | Cancer Discov | 2023 | 37682219 | PubTator, text mining | PubMed |
| HIV-1 Vpr induces ciTRAN to prevent transcriptional repression of the provirus. | Sci Adv | 2023 | 37672576 | PubTator, text mining | PubMed |
| Pyrimidine metabolism regulator-mediated molecular subtypes display tumor microenvironmental hallmarks and assist precision treatment in bladder cancer. | Front Oncol | 2023 | 37664033 | PubTator, text mining | PubMed |
| A novel bivalent anti-c-MET/PD-1 bispecific antibody exhibits potent cytotoxicity against c-MET/PD-L1-positive colorectal cancer. | Invest New Drugs | 2023 | 37646958 | PubTator, text mining | PubMed |
| The Role of GAB1 in Cancer. | Cancers (Basel) | 2023 | 37627207 | PubTator, text mining | PubMed |
| Imaging Markers in Genetic Forms of Parkinson's Disease. | Brain Sci | 2023 | 37626568 | PubTator, text mining | PubMed |
| Taking early preventive interventions to manage the challenging issue of acquired resistance to third-generation EGFR inhibitors. | Chin Med J Pulm Crit Care Med | 2023 | 37609474 | PubTator, text mining | PubMed |
| SHP2 is involved in the occurrence, development and prognosis of cancer. | Oncol Lett | 2023 | 37600341 | PubTator, text mining | PubMed |
| Discovery of oncogenic ROS1 missense mutations with sensitivity to tyrosine kinase inhibitors. | EMBO Mol Med | 2023 | 37587872 | PubTator, text mining | PubMed |
| Structural diversity of the region encompassing DIS, SD and Psi hairpins in HIV and SIV genomes. | Virus Res | 2023 | 37574135 | PubTator, text mining | PubMed |
| Anticancer effect of crizotinib on osteosarcoma cells by targeting c-Met signaling pathway. | Cell Mol Biol (Noisy-le-grand) | 2023 | 37571883 | PubTator, text mining | PubMed |
| Glucuronic acid metabolites of phenolic acids target AKT-PH domain to improve glucose metabolism. | Chin Herb Med | 2023 | 37538860 | PubTator, text mining | PubMed |
| Smurf1 and Smurf2 mediated polyubiquitination and degradation of RNF220 suppresses Shh-group medulloblastoma. | Cell Death Dis | 2023 | 37537194 | PubTator, text mining | PubMed |
| CSK-mediated signalling by integrins in cancer. | Front Cell Dev Biol | 2023 | 37519303 | PubTator, text mining | PubMed |
| The Development and Role of Capmatinib in the Treatment of MET-Dysregulated Non-Small Cell Lung Cancer-A Narrative Review. | Cancers (Basel) | 2023 | 37509224 | PubTator, text mining | PubMed |
| Current progress in cancer treatment by targeting FGFR signaling. | Cancer Biol Med | 2023 | 37493315 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2549/papers?page=8